findmyKOL
Clinical trialNCT05748834RecruitingPhase 2Interventional

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

SponsorSCRI Development Innovations, LLCEnrollment36Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Maryland Oncology Hematology

    Columbia, Maryland, United States

    Carol Tweed, MD
    Recruiting
  • Alliance Cancer Specialists

    Bensalem, Pennsylvania, United States

    Sramila Aithal, MD
    Recruiting
  • Scri Oncology Partners

    Nashville, Tennessee, United States

    Erika Hamilton, MD
    Recruiting
  • Tennessee Oncology

    Nashville, Tennessee, United States

    Active, not recruiting
  • Texas Oncology- Dfw

    Dallas, Texas, United States

    Joyce O'Shaughnessy, MD
    Recruiting
  • Texas Oncology- San Antonio

    San Antonio, Texas, United States

    Emmalind Aponte, MD
    Recruiting
  • Virginia Oncology Associates

    Norfolk, Virginia, United States

    Nino Balanchivadze, MD
    Recruiting
  • Blue Ridge Cancer Care (oncology & Hematology Assoc of Sw Virginia, Inc)

    Salem, Virginia, United States

    Amanda Gillespie-Twardy, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
24 Jul 2023
Primary completion
30 Nov 2027
Completion
30 Nov 2027
Last update posted
20 Mar 2026
Registered enrollment
36
Registry id
NCT05748834
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.